Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

News and Opinion from the Pandemic Sciences Institute at the University of Oxford

Abstract submissions open for International Pandemic Sciences Conference 2025

Abstract and bursary submissions are now open for the International Pandemic Sciences Conference 2025 – Getting Ahead of the Curve.

Study provides new insights into mpox clinical outcomes and transmission

Results of MOSAIC, a European observational study led by researchers at PSI and ISARIC, provides evidence on how the clade IIb mpox virus affects patients and the risks of onward transmission.

Pig research paves way for human respiratory vaccine development

A study in pigs, which shows that inhaled vaccines could potentially reduce viral transmission and improve efficiency, is an important step toward advancing vaccines for human use.

Registration now open for International Pandemic Sciences Conference 2025

Representatives from academia, industry, civil society, and the public sector are invited to register for the International Pandemic Sciences Conference 2025, taking place in Oxford and online from 30 June to 1 July 2025.

Optimising testing for disease surveillance with machine learning

A new machine learning-informed strategy could support public health leaders to design better disease surveillance during a disease outbreak.

PSI’s Md Zakiul Hassan recognised as 2024 ISID Emerging Leader

The award from the International Society for Infectious Diseases acknowledges early-career excellence in the field.

Nipah Virus Research Day showcases cross-disciplinary advances

Over 100 researchers convened for a PSI-hosted event exploring the latest interdisciplinary research to combat this deadly virus.

WHO’s Dr Chikwe Ihekweazu shares public health leadership insights at PSI seminar

Launching his new book, the WHO Assistant Director-General and former Director General of the Nigeria Centre for Disease Control (NCDC) shared his experience as a frontline policymaker leading a burgeoning national public health institute in the face of COVID-19.

Partnership with Universiti Malaysia Sabah to advance understanding of emerging viruses

PSI has signed a Memorandum of Understanding with Universiti Malaysia Sabah (UMS), to advance a shared understanding of the risks of emerging viruses in regions rich in biodiversity.

University of Oxford unveils new vaccine development partnership

Oxford Cancer, the Oxford Vaccine Group and the Pandemic Sciences Institute have announced a new collaboration with Belgian biotech innovator Univercells.

New study traces impact of COVID-19 pandemic on global movement and evolution of seasonal flu

Increased genomic surveillance capacity allowed a deeper insight into the global distribution patterns of seasonal flu and other respiratory viruses.

Reconstructing a lifetime of flu infections to understand long-term trends

Using antibody data and mathematical modelling, a new study estimates annual patterns of influenza infection and protection over the past fifty years.

£5.5m funding boost for health protection research on emerging and zoonotic infections

University of Oxford collaborators from the Pandemic Sciences Institute and the Department of Statistics will keep contributing actively to the new iteration of the Health Protection Research Unit in Emerging and Zoonotic Infections.

Professor David Aanensen honoured with 2025 Translational Microbiology Prize

The award recognises the PSI Investigator’s work in the areas of translational microbiology and genomic epidemiology.

Moh Family Foundation visit highlights vital support for pandemic preparedness research

The Pandemic Sciences Institute welcomed the Moh Family Foundation to Oxford to share latest research updates and celebrate the Foundation’s generous support.

Large-scale study on Long Covid highlights urgent, global need for investment

A new study in BMJ Global Health reveals the key Long Covid characteristics affecting populations worldwide, including fatigue, shortness of breath and having trouble thinking clearly. 6-12 months after hospital discharge, 70% of study participants were affected by Long Covid in high-income countries, and 42% in low and middle-income countries.

Study suggests possible new transmission route for highly pathogenic avian influenza

Understanding actual “bird flu” rates in humans will help prevent further spillover and a potential new pandemic.

Study explores aerosol immunisation as path to broadly protective influenza vaccine

Scientists at PSI and Pirbright have taken a significant step towards developing a universal influenza vaccine.

New multidisciplinary programme to develop digital pandemic tools

The Oxford Martin Programme on Digital Pandemic Preparedness will be co-led by researchers affiliated with the Pandemic Sciences Institute.

PSI seminar series launches with talk on pandemic control measures

Leading infectious disease epidemiologist Professor Adam Kucharski presented on opportunities to generate key insights into pandemic pathogens while implementing outbreak control measures, using insights from COVID-19, as part of a new series of pandemic sciences seminars.

Load More